NO20070570L - Forbindelser. - Google Patents
Forbindelser.Info
- Publication number
- NO20070570L NO20070570L NO20070570A NO20070570A NO20070570L NO 20070570 L NO20070570 L NO 20070570L NO 20070570 A NO20070570 A NO 20070570A NO 20070570 A NO20070570 A NO 20070570A NO 20070570 L NO20070570 L NO 20070570L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- preparation
- pharmaceutical preparations
- therapy
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Forbindelser av formel (I): hvor R1 og R2 er som definert i beskrivelsen og kravene; fremgangsmåter for deres fremstilling; farmasøytiske preparater som inneholder dem; en fremgangsmåte for fremstilling av de farmasøytiske preparatene; og deres anvendelse i terapi.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0401763A SE0401763D0 (sv) | 2004-07-05 | 2004-07-05 | Compounds |
PCT/SE2005/001093 WO2006004533A1 (en) | 2004-07-05 | 2005-07-04 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20070570L true NO20070570L (no) | 2007-04-10 |
Family
ID=32768774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20070570A NO20070570L (no) | 2004-07-05 | 2007-01-30 | Forbindelser. |
Country Status (18)
Country | Link |
---|---|
US (1) | US20080004317A1 (no) |
EP (1) | EP1794147A1 (no) |
JP (1) | JP2008505172A (no) |
KR (1) | KR20070038498A (no) |
CN (1) | CN1980915A (no) |
AR (1) | AR049577A1 (no) |
AU (1) | AU2005260143B2 (no) |
BR (1) | BRPI0512986A (no) |
CA (1) | CA2569727A1 (no) |
IL (1) | IL179907A0 (no) |
MX (1) | MXPA06014663A (no) |
NO (1) | NO20070570L (no) |
SA (1) | SA05260190B1 (no) |
SE (1) | SE0401763D0 (no) |
TW (1) | TW200605888A (no) |
UY (1) | UY29003A1 (no) |
WO (1) | WO2006004533A1 (no) |
ZA (1) | ZA200610701B (no) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0100902D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0100903D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0202539D0 (sv) * | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
US7648992B2 (en) | 2004-07-05 | 2010-01-19 | Astrazeneca Ab | Hydantoin derivatives for the treatment of obstructive airway diseases |
SE0401762D0 (sv) * | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
SE0403085D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Novel componds |
SE0403086D0 (sv) | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Compounds |
CA2601076C (en) * | 2005-03-16 | 2014-07-08 | Advanced Metering Data Systems, L.L.C. | Method, system, apparatus, and computer program product for determining a physical location of a sensor |
TW200740769A (en) | 2006-03-16 | 2007-11-01 | Astrazeneca Ab | Novel process |
TW200831488A (en) * | 2006-11-29 | 2008-08-01 | Astrazeneca Ab | Novel compounds |
WO2009007747A2 (en) * | 2007-07-11 | 2009-01-15 | Astrazeneca Ab | Hydantoin derivatives used as mmp12 inhibitors |
WO2010090680A1 (en) | 2008-12-15 | 2010-08-12 | Wyeth Llc | Substituted oxindole cb2 agonists |
KR20180041662A (ko) * | 2015-07-09 | 2018-04-24 | 미쓰비시 타나베 파마 코퍼레이션 | 신규 이미드 유도체 및 그 의약으로서의 용도 |
IT201700026858A1 (it) * | 2017-03-10 | 2018-09-10 | Univ Degli Studi Padova | Uso di inibitori delle serin proteasi, in particolare di serpinb3 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010052503A (ko) * | 1998-06-03 | 2001-06-25 | 다니엘 피. 맥컬럼 | N-헤테로사이클릭 카복실산 또는 카복실산 등입체의n-결합된 설폰아미드 |
AU4692399A (en) * | 1998-06-17 | 2000-01-05 | Du Pont Pharmaceuticals Company | Cyclic hydroxamic acids as metalloproteinase inhibitors |
US6340691B1 (en) * | 1999-01-27 | 2002-01-22 | American Cyanamid Company | Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors |
ATE319702T1 (de) * | 1999-08-02 | 2006-03-15 | Verfahren zur herstellung von benzothiophen- derivaten | |
US20020091107A1 (en) * | 2000-09-08 | 2002-07-11 | Madar David J. | Oxazolidinone antibacterial agents |
SE0100902D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0100903D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
EE200300439A (et) * | 2001-03-15 | 2003-12-15 | Astrazeneca Ab | Metalloproteinaasi inhibiitorid |
ATE445400T1 (de) * | 2001-05-25 | 2009-10-15 | Bristol Myers Squibb Co | Hydantion-derivate als hemmer von matrix- metalloproteinasen |
GB0114004D0 (en) * | 2001-06-08 | 2001-08-01 | Glaxo Group Ltd | Chemical compounds |
SE0103710D0 (sv) * | 2001-11-07 | 2001-11-07 | Astrazeneca Ab | Compounds |
SE0202539D0 (sv) * | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
SE0202693D0 (sv) * | 2002-09-11 | 2002-09-11 | Astrazeneca Ab | Compounds |
GB0221250D0 (en) * | 2002-09-13 | 2002-10-23 | Astrazeneca Ab | Compounds |
GB0221246D0 (en) * | 2002-09-13 | 2002-10-23 | Astrazeneca Ab | Compounds |
TWI220073B (en) * | 2003-07-24 | 2004-08-01 | Au Optronics Corp | Method for manufacturing polysilicon film |
SE0401762D0 (sv) * | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
-
2004
- 2004-07-05 SE SE0401763A patent/SE0401763D0/xx unknown
-
2005
- 2005-06-29 SA SA5260190A patent/SA05260190B1/ar unknown
- 2005-06-29 TW TW094121767A patent/TW200605888A/zh unknown
- 2005-07-04 BR BRPI0512986-9A patent/BRPI0512986A/pt not_active IP Right Cessation
- 2005-07-04 MX MXPA06014663A patent/MXPA06014663A/es not_active Application Discontinuation
- 2005-07-04 EP EP05755334A patent/EP1794147A1/en not_active Withdrawn
- 2005-07-04 CA CA002569727A patent/CA2569727A1/en not_active Abandoned
- 2005-07-04 US US11/571,643 patent/US20080004317A1/en not_active Abandoned
- 2005-07-04 AU AU2005260143A patent/AU2005260143B2/en not_active Ceased
- 2005-07-04 CN CNA200580022806XA patent/CN1980915A/zh active Pending
- 2005-07-04 WO PCT/SE2005/001093 patent/WO2006004533A1/en active Application Filing
- 2005-07-04 JP JP2007520268A patent/JP2008505172A/ja active Pending
- 2005-07-04 KR KR1020077000187A patent/KR20070038498A/ko not_active Application Discontinuation
- 2005-07-05 UY UY29003A patent/UY29003A1/es not_active Application Discontinuation
- 2005-07-05 AR ARP050102792A patent/AR049577A1/es unknown
-
2006
- 2006-12-07 IL IL179907A patent/IL179907A0/en unknown
- 2006-12-19 ZA ZA200610701A patent/ZA200610701B/xx unknown
-
2007
- 2007-01-30 NO NO20070570A patent/NO20070570L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
SA05260190B1 (ar) | 2008-03-26 |
JP2008505172A (ja) | 2008-02-21 |
CN1980915A (zh) | 2007-06-13 |
TW200605888A (en) | 2006-02-16 |
KR20070038498A (ko) | 2007-04-10 |
AU2005260143A1 (en) | 2006-01-12 |
US20080004317A1 (en) | 2008-01-03 |
WO2006004533A1 (en) | 2006-01-12 |
MXPA06014663A (es) | 2007-02-12 |
AU2005260143B2 (en) | 2009-01-29 |
BRPI0512986A (pt) | 2008-04-22 |
UY29003A1 (es) | 2006-02-24 |
IL179907A0 (en) | 2007-05-15 |
CA2569727A1 (en) | 2006-01-12 |
ZA200610701B (en) | 2008-08-27 |
SE0401763D0 (sv) | 2004-07-05 |
EP1794147A1 (en) | 2007-06-13 |
AR049577A1 (es) | 2006-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20070570L (no) | Forbindelser. | |
NO20054329L (no) | Adamantanderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som innbefatter slike | |
NO20070576L (no) | Nye hydantionderivater for behandling av obstruktive luftveissykdommer. | |
NO20081729L (no) | Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer | |
NO20051695L (no) | Nye spirokondenserte kinazolinoner og deres anvendelse som fosfodiestereaseinbibitorer | |
NO20050525L (no) | Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer | |
SE0200920D0 (sv) | Novel compounds | |
NO20062335L (no) | Nye diazaspiroalkaner og deres anvendelse i behandlingen av CCR8 medierte sykdommer | |
NO20062591L (no) | Difenylazetidinonderivater med kolesterolabsorpsjonsinhiberende aktivitet | |
SE9904505D0 (sv) | Novel compounds | |
NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
NO20061363L (no) | Pyrazolo- og imidazo- pyrimidinderivater | |
TW200635917A (en) | Novel compounds | |
NO20074703L (no) | Antibakterielle piperidinderivater | |
SE0202539D0 (sv) | Compounds | |
NO20092412L (no) | Hydantoinderivater anvendes som MMP-inhibitorer | |
NO20062583L (no) | Difenylazetidinonderivater med kolesterolabsorpsjonsinhiberende aktivitet | |
NO20064201L (no) | Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling | |
NO20066055L (no) | Pyridinderivater | |
TW200639156A (en) | New compounds | |
NO20081217L (no) | Nye benzotiazolonderivater | |
NO20062021L (no) | Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika | |
TW200635916A (en) | Compounds | |
TW200738659A (en) | Novel compounds | |
HK1099751A1 (en) | Triazolone derivatives as mmp inhibitors for the treatment of asthma and copd |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |